About the Role
Define and own the growth platform strategy and roadmap, focusing on foundational capabilities that unlock conversion, activation, retention, and market scalability. You will translate platform investments into business outcomes, embed AI where it genuinely improves outcomes, enable dynamic experiences, and build a tech stack that launches new markets rapidly. This is a platform role focused on enabling patients and growth teams.
Responsibilities
- Define and own the growth platform strategy and roadmap
- Translate platform investments into business outcomes
- Embed AI where it genuinely improves outcomes
- Enable dynamic experiences across landing pages, onboarding, and in-product surfaces
- Build a tech stack that launches a new market in weeks, not months
Requirements
- Solid PM experience with meaningful time on platform, growth, data, or infrastructure
- Hold the technical and commercial view at once
- Comfortable with ambiguity
- Adaptable
- Comfortable working with data teams
- Strong cross-functional instincts
- Genuinely curious about where AI actually belongs in a product experience
Skills
- Platform strategy
- Roadmap ownership
- AI implementation
- Personalization
- Authentication
- CMS
- Feature flagging
- Content infrastructure
- Event tracking
- User identity
- Data models
Location
- Old Street
Work Type
- Hybrid
- Full-time
Experience Level
- Mid-level
Benefits
- Employee options program
- Newly opened HQ in vibrant Old Street
- Flexible hybrid setup
- Monthly wellness allowance
- Yearly personal development budget
- 3 extra days of leave
- 25 days holiday + bank holidays
- Enhanced parental leave policy
- Fun office with regular socials
- MacBook
About the Company
- Eucalyptus is on a mission to make good health last a lifetime, building better long-term care.
- Eucalyptus is now part of Hims & Hers, a global leader in personalized health and wellness.
- Eucalyptus is the company behind Juniper, a large weight-management program combining GLP-1 medication with personalized nutrition, movement support, and clinician-led care.
- Eucalyptus has achieved 130% YoY revenue growth and a 90% reduction in cash burn.
- Eucalyptus was acquired by Hims & Hers for $1.15bn in 2026.
- Eucalyptus has supported over 350k patients living with obesity across 5 markets.
- Eucalyptus has received selective NICE endorsement to provide services to the NHS.
- Eucalyptus has tailored its offering to patients in Australia, the UK, Germany, Japan and Canada.
Equal Opportunity
- At Eucalyptus, we value individuals from all backgrounds, experiences, and perspectives, and we embrace the unique qualities each person brings.
- We use AI-assisted tools across our business to help our teams work more efficiently, including within our recruitment process. These tools support our team — all hiring decisions are made by real people, and every application is reviewed by a member of our recruitment team.
